These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32560548)

  • 1. Regular Training Increases sTWEAK and Its Decoy Receptor sCD163-Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
    Schönbauer R; Lichtenauer M; Paar V; Emich M; Fritzer-Szekeres M; Schukro C; Strametz-Juranek J; Sponder M
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32560548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure.
    Ptaszynska-Kopczynska K; Marcinkiewicz-Siemion M; Lisowska A; Waszkiewicz E; Witkowski M; Jasiewicz M; Miklasz P; Jakim P; Galar B; Musial WJ; Kaminski KA
    Cytokine; 2016 Apr; 80():7-12. PubMed ID: 26916171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Guiducci S; Trzcinska-Butkiewicz B; Michalska-Jakubus M; Matucci-Cerinic M; Brzosko M; Krasowska D; Chyczewski L; Kowal K
    Arthritis Res Ther; 2013; 15(3):R69. PubMed ID: 23800379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
    Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
    Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.
    Moreno JA; Dejouvencel T; Labreuche J; Smadja DM; Dussiot M; Martin-Ventura JL; Egido J; Gaussem P; Emmerich J; Michel JB; Blanco-Colio LM; Meilhac O
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1253-62. PubMed ID: 20299688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study.
    Llauradó G; González-Clemente JM; Maymó-Masip E; Subías D; Vendrell J; Chacón MR
    PLoS One; 2012; 7(8):e43919. PubMed ID: 22937125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of high sCD163/sTWEAK ratio with cardiovascular disease in hemodialysis patients.
    Rusu CC; Racasan S; Kacso IM; Ghervan L; Moldovan D; Potra A; Patiu IM; Bondor C; Caprioara MG
    Int Urol Nephrol; 2015 Dec; 47(12):2023-30. PubMed ID: 26433887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic characteristics of pulmonary infection in hospitalized patients with chronic heart failure and diagnostic value of sTREM-1, sCD163, and sTWEAK.
    Zheng F
    Pak J Med Sci; 2022; 38(3Part-I):536-541. PubMed ID: 35480505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of CD163 and TWEAK in patients with pulmonary arterial hypertension.
    Jasiewicz M; Kowal K; Kowal-Bielecka O; Knapp M; Skiepko R; Bodzenta-Lukaszyk A; Sobkowicz B; Musial WJ; Kaminski KA
    Cytokine; 2014 Mar; 66(1):40-5. PubMed ID: 24548423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced circulating levels of TWEAK are associated with gestational diabetes mellitus.
    Simón-Muela I; Llauradó G; Chacón MR; Olona M; Näf S; Maymó-Masip E; Gil P; de la Flor M; Gonzalez Clemente JM; Vendrell J; Megía A
    Eur J Clin Invest; 2015 Jan; 45(1):27-35. PubMed ID: 25443800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.
    Dirajlal-Fargo S; Sattar A; Kulkarni M; Funderburg N; McComsey GA
    HIV Clin Trials; 2017 Jul; 18(4):156-163. PubMed ID: 28828963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease.
    Ilter A; Orem C; Balaban Yucesan F; Sahin M; Hosoglu Y; Kurumahmutoglu E; Ozer Yaman S; Orem A
    Int J Clin Exp Med; 2015; 8(6):9394-402. PubMed ID: 26309601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
    Valdivielso JM; Coll B; Martín-Ventura JL; Moreno JA; Egido J; Fernández E; Blanco-Colio LM
    J Nephrol; 2013; 26(6):1105-13. PubMed ID: 23475462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of circulating TWEAK and CD163 as biomarkers of iron-induced cardiac decompensation in transfusion dependent thalassemia major.
    Watany MM; Elhosary MM
    Cytokine; 2024 Jan; 173():156443. PubMed ID: 38000169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance.
    Dereke J; Nilsson J; Nilsson C; Strevens H; Landin-Olsson M; Hillman M
    PLoS One; 2019; 14(5):e0216728. PubMed ID: 31071174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum sTWEAK concentrations and risk of developing type 2 diabetes in a high cardiovascular risk population: a nested case-control study.
    Díaz-López A; Chacón MR; Bulló M; Maymó-Masip E; Martínez-González MA; Estruch R; Vendrell J; Basora J; Díez-Espino J; Covas MI; Salas-Salvadó J
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3482-90. PubMed ID: 23760626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of resveratrol supplementation on PPARα, p16, p53, p21 gene expressions, and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: A double-blind controlled randomized trial.
    Toupchian O; Abdollahi S; Salehi-Abargouei A; Heshmati J; Clark CCT; Sheikhha MH; Fallahzadeh H; Mozaffari-Khosravi H
    Phytother Res; 2021 Jun; 35(6):3205-3213. PubMed ID: 33580595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sCD163 and sTWEAK in patients with stable peripheral arterial disease and association with disease severity as well as long-term mortality.
    Mrak D; Zierfuss B; Höbaus C; Herz CT; Pesau G; Schernthaner GH
    Atherosclerosis; 2021 Jan; 317():41-46. PubMed ID: 33378730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the Di@bet.es study.
    Rojo-Martínez G; Maymó-Masip E; Rodríguez MM; Solano E; Goday A; Soriguer F; Valdés S; Chaves FJ; Delgado E; Colomo N; Hernández P; Vendrell J; Chacón MR
    PLoS One; 2014; 9(6):e101250. PubMed ID: 24978196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of probiotic yogurt versus ordinary yogurt on serum sTWEAK, sCD163, ADMA, LCAT and BUN in patients with chronic heart failure: a randomized, triple-blind, controlled trial.
    Pourrajab B; Naderi N; Janani L; Hajahmadi M; Mofid V; Dehnad A; Sohouli MH; Hosseini S; Shidfar F
    J Sci Food Agric; 2022 Oct; 102(13):6024-6035. PubMed ID: 35460085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.